Ashtral Biotech Profile
Key Indicators
- Authorised Capital ₹ 0.45 M
as on 01-01-2025
- Paid Up Capital ₹ 0.18 M
as on 01-01-2025
- Company Age 11 Year, 11 Days
- Last Filing with ROC 31 Mar 2020
- Revenue -61.56%
(FY 2020)
- Profit 85.35%
(FY 2020)
- Ebitda 96.77%
(FY 2020)
- Net Worth -6.75%
(FY 2020)
- Total Assets -1.44%
(FY 2020)
About Ashtral Biotech
The Company is engaged in the Food And Beverages Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2020. It's a company limited by shares with an authorized capital of Rs 0.45 M and a paid-up capital of Rs 0.18 M, as per Ministry of Corporate Affairs (MCA) records.
Kanav Parwal, Sudhir Rebala, Alla Muralikrishnareddy, and Two other members serve as directors at the Company.
- CIN/LLPIN
U01402TN2014PTC094530
- Company No.
094530
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
09 Jan 2014
- Date of AGM
31 Dec 2020
- Date of Balance Sheet
31 Mar 2020
- Listing Status
Unlisted
- ROC Code
Roc Chennai
Industry
Company Details
- Location
Kanchipuram, Tamil Nadu, India
- Telephone
- Email Address
- Website
- Social Media
Who are the key members and board of directors at Ashtral Biotech?
Executive Team (1)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Sudhir Rebala  | Managing Director | 09-Jan-2014 | Current |
Board Members(4)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Varun Khandelwal | Director | 29-Sep-2016 | Current |
| Kanav Parwal | Director | 29-Sep-2016 | Current |
| Alla Muralikrishnareddy | Director | 09-Jan-2014 | Current |
| Lakshmi Veluru | Director | 15-Jun-2022 | Current |
Financial Performance of Ashtral Biotech.
Ashtral Biotech Private Limited, for the financial year ended 2020, experienced significant reduction in revenue, with a 61.56% decrease. The company also saw a substantial improvement in profitability, with a 85.35% increase in profit. The company's net worth dipped by a decrease of 6.75%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Ashtral Biotech?
Unlock access to Ashtral Biotech's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Related Corporates (Common Directorship)
Greykernel Technologies India Private LimitedActive 9 years 11 monthsKanav Parwal is a mutual person
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Ashtral Biotech?
Unlock and access historical data on people associated with Ashtral Biotech, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Ashtral Biotech, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Ashtral Biotech's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
